SCHEMBL13163934

SCHEMBL13163934

COCCCOc1ccc(N)c(C(=O)OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
KDM4E B2RXH2 5/20 0.55
HSD17B10 Q99714 4/20 0.55
MAPT P10636 4/20 0.55
HPGD P15428 3/20 0.55
GAA P10253 3/20 0.55
ALOX15 P16050 1/20 0.55
TSHR P16473 1/20 0.55
CFTR P13569 1/20 0.46
GLA P06280 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
ATM Q13315 1/20 0.43
MAOB P27338 5/20 0.43
MAOA P21397 3/20 0.43
TP53 P04637 1/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ABL1 P00519 1/20 0.42
GCK P35557 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL267612 0.93 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL4257305 0.90 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL1012515 0.88 KDM4E (0.55) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL13163939 0.87 ALDH1A1 (0.51) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL23882144 0.87 ALDH1A1 (0.46) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL7452382 0.87 KDM4E (0.56) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL30710211 0.86 MAPT (0.52) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL13162549 0.85 KDM4E (0.51) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL13162397 0.84 HPGD (0.48) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL23757486 0.83 ALDH1A1 (0.50) ALDH1A1KDM4EHSD17B10MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249088-A1 AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249088-A1 AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF TRPV1, FGFR3, GPR17 ALDH1A1 1659/4885KDM4E 1395/4885HSD17B10 3992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.